skip to main content

Valproate safety materials — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardAdverse Drug Reactions and Drug SafetyValproate safety materialsGPhC CRA

A woman of childbearing potential taking valproate says she has not received updated risk information. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Provide required safety materials and advise specialist review of pregnancy prevention requirements

Valproate risk minimisation requires active counselling and safety materials. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.

Reference: MHRA; BNF